The newly developed Migraine Aura Complexity Score is effective for stratifying patients with migraine with aura.
Researchers found that a poor night’s sleep may increase risk for migraine the following day, rather than the next morning.
Cannabis use among patients with multiple sclerosis is more likely where cannabis laws are more permissive.
The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine with or without aura in adults. The approval was supported by two pivotal phase 3, randomized, double-blind, placebo-controlled trials (ACHIEVE I and ACHIEVE II) that evaluated the efficacy,…
The aim of this study was to determine whether inhalation of cannabis decreases headache and migraine rating and whether sex, type of cannabis (concentrate vs flower), THC, CBD, or dose are contributing factors to changes in these ratings.
Various migraine subgroups based on comorbidities can predict the risk for the progression of episodic migraine to chronic migraine.
In Iran, researchers found data that showed a correlation of migraines with gastroesophageal reflux disease, Helicobacter pylori infection, and duodenal ulcer.
Evidence supports the use of high-dose aspirin for treating acute migraine and low-dose aspirin for prevention of recurrent attacks.
Revised criteria from the third edition of the International Classification of Headache Disorders (ICHD-3), can differentiate between chronic cluster headache (CCH) and episodic cluster headache (ECH) and may increase the number of CCH diagnoses.
In patients with chronic nonmigraine headaches, onabotulinum toxin type A injections may reduce pain severity and frequency of headaches.